Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitors-Reference-Cited by-同舟云学术

Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitors

Published:2022-05 Issue: Volume:166 Page:87-99
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Paulet Lola,Trecourt Alexis,Leary Alexandra^ORCID,Peron Julien,Descotes Françoise,Devouassoux-Shisheboran Mojgan,Leroy Karen^ORCID,You Benoit,Lopez Jonathan^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference67 articles.

1. The DNA Damage Response: making it safe to play with knives;Ciccia;Mol Cell,2010

2. Integrated genomic analyses of ovarian carcinoma;Nature,2011

3. BRCAness revisited;Lord;Nat Rev Cancer,2016

4. Mechanisms of PARP inhibitor sensitivity and resistance;D'Andrea;DNA Repair,2018

5. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer;Moore;N Engl J Med,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas;Cell Death & Disease;2024-07-22

2. Molecular dynamics of DNA repair and carcinogen interaction: Implications for cancer initiation, progression, and therapeutic strategies;Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis;2024-07

3. Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation;Biomarker Research;2024-05-04

4. A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2;Cell;2024-04

5. Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study;European Urology Oncology;2024-03